Literature DB >> 19135439

Mitogen-activated protein kinase 3/mitogen-activated protein kinase 1 activates apoptosis during testicular ischemia-reperfusion injury in a nuclear factor-kappaB-independent manner.

Letteria Minutoli1, Pietro Antonuccio, Francesca Polito, Alessandra Bitto, Francesco Squadrito, Vincenzo Di Stefano, Piero Antonio Nicotina, Carmine Fazzari, Daniele Maisano, Carmelo Romeo, Domenica Altavilla.   

Abstract

Nuclear factor kappa-B (NF-kappaB), mitogen-activated protein kinase3/MAPK1 and MAPK8 are involved in testicular ischemia reperfusion injury (testicular-I/R). NF-kappaB knock-out mice (KO) subjected to testicular-I/R have a reduced testicular damage, blunted MAPK8 activation and enhanced MAPK3/MAPK1 activity. To better understand the role of MAPK3/MAPK1 up-regulation during testicular-I/R, we investigated the effects of PD98059, an inhibitor of MAPK3/MAPK1, in KO mice during testicular-I/R. KO and wild-type (WT) animals underwent 1 h testicular ischemia followed by 24 h reperfusion or a sham testicular-I/R. Animals received either PD98059 (5 mg/kg/ip) or its vehicle. MAPK3/MAPK1, BAX, caspase-3 and -9 and TNF-alpha expression were assessed along with histological examination and an immunostaining for protein of apoptosis. Testicular-I/R caused a greater increase in MAPK3/MAPK1 in KO than in WT animals in both testes. KO mice had a lower expression of the apoptotic proteins and TNF-alpha as well as reduced histological damage compared to WT. Immunostaining confirmed the lower expression of BAX in the Leydig cells of KO mice. Administration of PD98059, abrogated MAPK3/MAPK1 expression and slightly reduced TNF-alpha but did not improve or reverse the histological damage in KO. PD98059 significantly reduced the histological damage in WT mice and markedly reduced the apoptotic proteins in KO and WT mice. These results suggest that testicular-I/R triggers also a pathway of organ damage involving MAPK3/MAPK1, TNF-alpha, BAX, caspase-3 and -9 that activates an apoptotic machinery in an NF-kappaB independent manner. These findings should contribute to better understand testicular torsion-induced damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19135439     DOI: 10.1016/j.ejphar.2008.12.028

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Medical perspective in testicular ischemia-reperfusion injury.

Authors:  Salvatore Arena; Roberta Iacona; Pietro Antonuccio; Tiziana Russo; Vincenzo Salvo; Eloisa Gitto; Pietro Impellizzeri; Carmelo Romeo
Journal:  Exp Ther Med       Date:  2017-03-30       Impact factor: 2.447

2.  Melanocortin 4 receptor activation protects against testicular ischemia-reperfusion injury by triggering the cholinergic antiinflammatory pathway.

Authors:  Letteria Minutoli; Alessandra Bitto; Francesco Squadrito; Natasha Irrera; Mariagrazia Rinaldi; Piero Antonio Nicotina; Salvatore Arena; Carlo Magno; Herbert Marini; Luca Spaccapelo; Alessandra Ottani; Daniela Giuliani; Carmelo Romeo; Salvatore Guarini; Pietro Antonuccio; Domenica Altavilla
Journal:  Endocrinology       Date:  2011-08-09       Impact factor: 4.736

3.  Trehalose-Carnosine Prevents the Effects of Spinal Cord Injury Through Regulating Acute Inflammation and Zinc(II) Ion Homeostasis.

Authors:  Alessia Filippone; Irene Paterniti; Irina Naletova; Valentina Greco; Sebastiano Sciuto; Emanuela Esposito; Salvatore Cuzzocrea; Enrico Rizzarelli
Journal:  Cell Mol Neurobiol       Date:  2022-09-19       Impact factor: 4.231

4.  ICA II Alleviates Testicular Torsion Injury by Dampening the Oxidative and Inflammatory Stress.

Authors:  Ani Chi; Bicheng Yang; Xiaohui Cao; Zhenqing Wang; Hanchao Liu; Hao Dai; Chunhua Deng; Min Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-12       Impact factor: 6.055

Review 5.  ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury.

Authors:  Letteria Minutoli; Domenico Puzzolo; Mariagrazia Rinaldi; Natasha Irrera; Herbert Marini; Vincenzo Arcoraci; Alessandra Bitto; Giovanni Crea; Antonina Pisani; Francesco Squadrito; Vincenzo Trichilo; Daniele Bruschetta; Antonio Micali; Domenica Altavilla
Journal:  Oxid Med Cell Longev       Date:  2016-04-05       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.